drugset / Trial / NCT04640012
Ascending-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics of DC371739 Single-Dose Treatment in Healthy Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is to evaluate the safety, tolerability, pharmacokinetics of DC371739 after a single-dose oral administration in healthy Chinese subjects, and to explore the maximum tolerated dose, also the pharmacokinetics of urine and feces.
Timeline
- Start
- 2020-09-25
- Primary completion
- 2021-03-19
- Completion
- 2022-03-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DC371739 | Small molecule | 30 mg | Oral |
| Subject | DC371739 | Small molecule | 50 mg | Oral |
| Subject | DC371739 | Small molecule | 100 mg | Oral |
| Subject | DC371739 | Small molecule | 200 mg | Oral |
| Subject | DC371739 | Small molecule | 400 mg | Oral |
| Subject | DC371739 | Small molecule | 600 mg | Oral |